Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Issue Cover for Volume 29, Number 5—May 2023

Volume 29, Number 5—May 2023

[PDF - 8.98 MB - 220 pages]

Synopses

Medscape CME Activity
Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020 [PDF - 1003 KB - 11 pages]
C. M. Okafor et al.

Recurrent Clostridioides difficile infection (RCDI) causes an increased burden on the healthcare system. We calculated RCDI incidence and identified factors associated with RCDI cases in New Haven County, Connecticut, USA, during 2015–2020 by using data from population-based laboratory surveillance. A subset of C. difficile cases had complete chart reviews conducted for RCDI and potentially associated variables. RCDI was defined as a positive C. difficile specimen occurring 2–8 weeks after incident C. difficile infection. We compared cases with and without RCDI by using multiple regression. RCDI occurred in 12.0% of 4,301 chart-reviewed C. difficile cases, showing a U-shaped time trend with a sharp increase in 2020, mostly because of an increase in hospital-onset cases. Malignancy (odds ratio 1.51 [95% CI 1.11–2.07]) and antecedent nitrofurantoin use (odds ratio 2.37 [95% CI 1.23–4.58]) were medical risk factors for RCDI. The 2020 increase may reflect the impact of the COVID-19 pandemic.

EID Okafor CM, Clogher P, Olson D, Niccolai L, Hadler J. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020. Emerg Infect Dis. 2023;29(5):877-887. https://doi.org/10.3201/eid2905.221294
AMA Okafor CM, Clogher P, Olson D, et al. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020. Emerging Infectious Diseases. 2023;29(5):877-887. doi:10.3201/eid2905.221294.
APA Okafor, C. M., Clogher, P., Olson, D., Niccolai, L., & Hadler, J. (2023). Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020. Emerging Infectious Diseases, 29(5), 877-887. https://doi.org/10.3201/eid2905.221294.

Phylogenetic Analysis of Transmission Dynamics of Dengue in Large and Small Population Centers, Northern Ecuador [PDF - 2.87 MB - 10 pages]
S. Márquez et al.

Although dengue is typically considered an urban disease, rural communities are also at high risk. To clarify dynamics of dengue virus (DENV) transmission in settings with characteristics generally considered rural (e.g., lower population density, remoteness), we conducted a phylogenetic analysis in 6 communities in northwestern Ecuador. DENV RNA was detected by PCR in 121/488 serum samples collected from febrile case-patients during 2019–2021. Phylogenetic analysis of 27 samples from Ecuador and other countries in South America confirmed that DENV-1 circulated during May 2019–March 2020 and DENV-2 circulated during December 2020–July 2021. Combining locality and isolation dates, we found strong evidence that DENV entered Ecuador through the northern province of Esmeraldas. Phylogenetic patterns suggest that, within this province, communities with larger populations and commercial centers were more often the source of DENV but that smaller, remote communities also play a role in regional transmission dynamics.

EID Márquez S, Lee G, Gutiérrez B, Bennett S, Coloma J, Eisenberg J, et al. Phylogenetic Analysis of Transmission Dynamics of Dengue in Large and Small Population Centers, Northern Ecuador. Emerg Infect Dis. 2023;29(5):888-897. https://doi.org/10.3201/eid2905.221226
AMA Márquez S, Lee G, Gutiérrez B, et al. Phylogenetic Analysis of Transmission Dynamics of Dengue in Large and Small Population Centers, Northern Ecuador. Emerging Infectious Diseases. 2023;29(5):888-897. doi:10.3201/eid2905.221226.
APA Márquez, S., Lee, G., Gutiérrez, B., Bennett, S., Coloma, J., Eisenberg, J....Trueba, G. (2023). Phylogenetic Analysis of Transmission Dynamics of Dengue in Large and Small Population Centers, Northern Ecuador. Emerging Infectious Diseases, 29(5), 888-897. https://doi.org/10.3201/eid2905.221226.
Research

Medscape CME Activity
Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021 [PDF - 2.96 MB - 11 pages]
L. M. Powell et al.

Clindamycin and β-lactam antibiotics have been mainstays for treating invasive group A Streptococcus (iGAS) infection, yet such regimens might be limited for strains displaying MLSB phenotypes. We investigated 76 iGAS isolates from 66 patients in West Virginia, USA, during 2020–2021. We performed emm typing using Centers for Disease Control and Prevention guidelines and assessed resistance both genotypically and phenotypically. Median patient age was 42 (range 23–86) years. We found 76% of isolates were simultaneously resistant to erythromycin and clindamycin, including all emm92 and emm11 isolates. Macrolide resistance was conferred by the plasmid-borne ermT gene in all emm92 isolates and by chromosomally encoded ermA, ermB, and a single mefA in other emm types. Macrolide-resistant iGAS isolates were typically resistant to tetracycline and aminoglycosides. Vulnerability to infection was associated with socioeconomic status. Our results show a predominance of macrolide-resistant isolates and a shift in emm type distribution compared with historical reports.

EID Powell LM, Choi S, Chipman CE, Grund ME, LaSala P, Lukomski S. Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021. Emerg Infect Dis. 2023;29(5):897-907. https://doi.org/10.3201/eid2905.221421
AMA Powell LM, Choi S, Chipman CE, et al. Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021. Emerging Infectious Diseases. 2023;29(5):897-907. doi:10.3201/eid2905.221421.
APA Powell, L. M., Choi, S., Chipman, C. E., Grund, M. E., LaSala, P., & Lukomski, S. (2023). Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021. Emerging Infectious Diseases, 29(5), 897-907. https://doi.org/10.3201/eid2905.221421.

Environmental, Occupational, and Demographic Risk Factors for Clinical Scrub Typhus, Bhutan [PDF - 1.38 MB - 10 pages]
T. Zangpo et al.

Underdiagnosis and underreporting of scrub typhus has increasingly affected public health in Bhutan since its initial detection in 2008. Identifying scrub typhus risk factors would support early diagnosis and treatment for this nonspecific febrile disease, reducing the incidence of potentially fatal complications. We conducted a hospital-based, case‒control study during October‒December 2015 in 11 scrub typhus‒prone districts. We identified harvesting cardamom as the major risk factor (odds ratio 1,519; p<0.001); other factors were traditional housing, largely caused by an outside toilet location, as well as owning a goat and frequently sitting on grass. Harvesting vegetables, herding cattle in the forest, and female sex were protective. Age had a nonlinear effect; children and the elderly were more likely to seek treatment for clinical scrub typhus. This study has informed public health policies and awareness programs for healthcare workers through development of National Guidelines for Prevention, Treatment and Control of Scrub Typhus in Bhutan.

EID Zangpo T, Phuentshok Y, Dorji K, Dorjee C, Dorjee S, Jolly P, et al. Environmental, Occupational, and Demographic Risk Factors for Clinical Scrub Typhus, Bhutan. Emerg Infect Dis. 2023;29(5):909-918. https://doi.org/10.3201/eid2905.221430
AMA Zangpo T, Phuentshok Y, Dorji K, et al. Environmental, Occupational, and Demographic Risk Factors for Clinical Scrub Typhus, Bhutan. Emerging Infectious Diseases. 2023;29(5):909-918. doi:10.3201/eid2905.221430.
APA Zangpo, T., Phuentshok, Y., Dorji, K., Dorjee, C., Dorjee, S., Jolly, P....McKenzie, J. (2023). Environmental, Occupational, and Demographic Risk Factors for Clinical Scrub Typhus, Bhutan. Emerging Infectious Diseases, 29(5), 909-918. https://doi.org/10.3201/eid2905.221430.

Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019–2020 [PDF - 893 KB - 10 pages]
J. A. Ramirez et al.

Although Clostridioides difficile infection (CDI) incidence is high in the United States, standard-of-care (SOC) stool collection and testing practices might result in incidence overestimation or underestimation. We conducted diarrhea surveillance among inpatients >50 years of age in Louisville, Kentucky, USA, during October 14, 2019–October 13, 2020; concurrent SOC stool collection and CDI testing occurred independently. A study CDI case was nucleic acid amplification test‒/cytotoxicity neutralization assay‒positive or nucleic acid amplification test‒positive stool in a patient with pseudomembranous colitis. Study incidence was adjusted for hospitalization share and specimen collection rate and, in a sensitivity analysis, for diarrhea cases without study testing. SOC hospitalized CDI incidence was 121/100,000 population/year; study incidence was 154/100,000 population/year and, in sensitivity analysis, 202/100,000 population/year. Of 75 SOC CDI cases, 12 (16.0%) were not study diagnosed; of 109 study CDI cases, 44 (40.4%) were not SOC diagnosed. CDI incidence estimates based on SOC CDI testing are probably underestimated.

EID Ramirez JA, Angulo FJ, Carrico RM, Furmanek S, Oliva S, Zamparo JM, et al. Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019–2020. Emerg Infect Dis. 2023;29(5):919-928. https://doi.org/10.3201/eid2905.221618
AMA Ramirez JA, Angulo FJ, Carrico RM, et al. Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019–2020. Emerging Infectious Diseases. 2023;29(5):919-928. doi:10.3201/eid2905.221618.
APA Ramirez, J. A., Angulo, F. J., Carrico, R. M., Furmanek, S., Oliva, S., Zamparo, J. M....Jodar, L. (2023). Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019–2020. Emerging Infectious Diseases, 29(5), 919-928. https://doi.org/10.3201/eid2905.221618.

SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May–July 2021 [PDF - 508 KB - 8 pages]
S. C. O’Brien et al.

To compare SARS-CoV-2 antibody seroprevalence among children with seropositive confirmed COVID-19 case counts (case ascertainment by molecular amplification) in Colorado, USA, we conducted a cross-sectional serosurvey during May–July 2021. For a convenience sample of 829 Colorado children, SARS-CoV-2 seroprevalence was 36.7%, compared with prevalence of 6.5% according to individually matched COVID-19 test results reported to public health. Compared with non-Hispanic White children, seroprevalence was higher among Hispanic, non-Hispanic Black, and non-Hispanic other race children, and case ascertainment was significantly lower among Hispanic and non-Hispanic Black children. This serosurvey accurately estimated SARS-CoV-2 prevalence among children compared with confirmed COVID-19 case counts and revealed substantial racial/ethnic disparities in infections and case ascertainment. Continued efforts to address racial and ethnic differences in disease burden and to overcome potential barriers to case ascertainment, including access to testing, may help mitigate these ongoing disparities.

EID O’Brien SC, Cole LD, Albanese BA, Mahon A, Knight V, Williams N, et al. SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May–July 2021. Emerg Infect Dis. 2023;29(5):929-936. https://doi.org/10.3201/eid2905.221541
AMA O’Brien SC, Cole LD, Albanese BA, et al. SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May–July 2021. Emerging Infectious Diseases. 2023;29(5):929-936. doi:10.3201/eid2905.221541.
APA O’Brien, S. C., Cole, L. D., Albanese, B. A., Mahon, A., Knight, V., Williams, N....Dominguez, S. R. (2023). SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May–July 2021. Emerging Infectious Diseases, 29(5), 929-936. https://doi.org/10.3201/eid2905.221541.

Disparities in Implementing COVID-19 Prevention Strategies in Public Schools, United States, 2021–22 School Year [PDF - 638 KB - 8 pages]
S. Pampati et al.

During the COVID-19 pandemic, US schools have been encouraged to take a layered approach to prevention, incorporating multiple strategies to curb transmission of SARS-CoV-2. Using survey data representative of US public K–12 schools (N = 437), we determined prevalence estimates of COVID-19 prevention strategies early in the 2021–22 school year and describe disparities in implementing strategies by school characteristics. Prevalence of prevention strategies ranged from 9.3% (offered COVID-19 screening testing to students and staff) to 95.1% (had a school-based system to report COVID-19 outcomes). Schools with a full-time school nurse or school-based health center had significantly higher odds of implementing several strategies, including those related to COVID-19 vaccination. We identified additional disparities in prevalence of strategies by locale, school level, and poverty. Advancing school health workforce and infrastructure, ensuring schools use available COVID-19 funding effectively, and promoting efforts in schools with the lowest prevalence of infection prevention strategies are needed for pandemic preparedness.

EID Pampati S, Rasberry CN, Timpe Z, McConnell L, Moore S, Spencer P, et al. Disparities in Implementing COVID-19 Prevention Strategies in Public Schools, United States, 2021–22 School Year. Emerg Infect Dis. 2023;29(5):937-944. https://doi.org/10.3201/eid2905.221533
AMA Pampati S, Rasberry CN, Timpe Z, et al. Disparities in Implementing COVID-19 Prevention Strategies in Public Schools, United States, 2021–22 School Year. Emerging Infectious Diseases. 2023;29(5):937-944. doi:10.3201/eid2905.221533.
APA Pampati, S., Rasberry, C. N., Timpe, Z., McConnell, L., Moore, S., Spencer, P....Barrios, L. C. (2023). Disparities in Implementing COVID-19 Prevention Strategies in Public Schools, United States, 2021–22 School Year. Emerging Infectious Diseases, 29(5), 937-944. https://doi.org/10.3201/eid2905.221533.

Leishmania donovani Transmission Cycle Associated with Human Infection, Phlebotomus alexandri Sand Flies, and Hare Blood Meals, Israel [PDF - 2.89 MB - 11 pages]
L. Studentsky et al.

Cutaneous leishmaniasis caused by Leishmania major or L. tropica and visceral leishmaniasis caused by L. infantum have been reported in Israel. We collected Phlebotomus spp. sand flies in the Negev desert of southern Israel to identify circulating Leishmania spp. Of 22,636 trapped sand flies, 80% were P. alexandri. We sequenced Leishmania-specific internal transcribed spacer 1 fragments and K26 genes. Of 5,019 Phlebotomus female sand flies, 2.5% were Leishmania DNA–positive; 92% of infections were L. donovani. Phylogenetic analyses showed separate clustering of L. donovani and L. infantum. P. alexandri flies positive for L. donovani harbored blood meals from European hares. Leishmania DNA isolated from a patient with cutaneous leishmaniasis who lived in the survey area was identical to L. donovani from P. alexandri flies. We report circulation of L. donovani, a cause of visceral leishmaniasis, in southern Israel. Prompt diagnosis and Leishmania spp. identification are critical to prevent leishmaniasis progression.

EID Studentsky L, Orshan L, Akad F, Ben Avi I, Diaz D, Elbaz S, et al. Leishmania donovani Transmission Cycle Associated with Human Infection, Phlebotomus alexandri Sand Flies, and Hare Blood Meals, Israel. Emerg Infect Dis. 2023;29(5):945-955. https://doi.org/10.3201/eid2905.221657
AMA Studentsky L, Orshan L, Akad F, et al. Leishmania donovani Transmission Cycle Associated with Human Infection, Phlebotomus alexandri Sand Flies, and Hare Blood Meals, Israel. Emerging Infectious Diseases. 2023;29(5):945-955. doi:10.3201/eid2905.221657.
APA Studentsky, L., Orshan, L., Akad, F., Ben Avi, I., Diaz, D., Elbaz, S....Baneth, G. (2023). Leishmania donovani Transmission Cycle Associated with Human Infection, Phlebotomus alexandri Sand Flies, and Hare Blood Meals, Israel. Emerging Infectious Diseases, 29(5), 945-955. https://doi.org/10.3201/eid2905.221657.

Case–Control Study of Long COVID, Sapporo, Japan [PDF - 3.15 MB - 11 pages]
T. Asakura et al.

We conducted a cross-sectional survey among SARS-CoV-2–positive persons and negative controls in Sapporo, Japan, to clarify symptoms of long COVID. We collected responses from 8,018 participants, 3,694 case-patients and 3,672 controls. We calculated symptom prevalence for case-patients at 2–3, 4–6, 7–9, 10–12, and 13–18 months after illness onset. We used logistic regression, adjusted for age and sex, to estimate the odds ratio (OR) for each symptom and control reference. We calculated symptom prevalence by stratifying for disease severity, age, and sex. At 4–18 months from illness onset, ORs for anosmia, ageusia, dyspnea, alopecia, and brain fog were consistently >1, whereas ORs for common cold–like, gastrointestinal, and dermatologic symptoms were <1. Time trend ORs increased for diminished ability to concentrate, brain fog, sleep disturbance, eye symptoms, and tinnitus. Clinicians should focus on systemic, respiratory, and neuropsychiatric symptoms among long COVID patients.

EID Asakura T, Kimura T, Kurotori I, Kenichi K, Hori M, Hosogawa M, et al. Case–Control Study of Long COVID, Sapporo, Japan. Emerg Infect Dis. 2023;29(5):956-966. https://doi.org/10.3201/eid2905.221349
AMA Asakura T, Kimura T, Kurotori I, et al. Case–Control Study of Long COVID, Sapporo, Japan. Emerging Infectious Diseases. 2023;29(5):956-966. doi:10.3201/eid2905.221349.
APA Asakura, T., Kimura, T., Kurotori, I., Kenichi, K., Hori, M., Hosogawa, M....Tamakoshi, A. (2023). Case–Control Study of Long COVID, Sapporo, Japan. Emerging Infectious Diseases, 29(5), 956-966. https://doi.org/10.3201/eid2905.221349.

Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017–2018 [PDF - 1.56 MB - 10 pages]
H. Nguyen et al.

To assess sex disparities in tuberculosis in Vietnam, we conducted a nested, case–control study based on a 2017 tuberculosis prevalence survey. We defined the case group as all survey participants with laboratory–confirmed tuberculosis and the control group as a randomly selected group of participants with no tuberculosis. We used structural equation modeling to describe pathways from sex to tuberculosis according to an a priori conceptual framework. Our analysis included 1,319 participants, of whom 250 were case-patients. We found that sex was directly associated with tuberculosis prevalence (adjusted odds ratio for men compared with women 3.0 [95% CI 1.7–5.0]) and indirectly associated through other domains. The strong sex difference in tuberculosis prevalence is explained by a complex interplay of factors relating to behavioral and environmental risks, access to healthcare, and clinical manifestations. However, after controlling for all those factors, a direct sex effect remains that might be caused by biological factors.

EID Nguyen H, Brals D, Tiemersma E, Gasior R, Nguyen N, Nguyen H, et al. Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017–2018. Emerg Infect Dis. 2023;29(5):967-976. https://doi.org/10.3201/eid2905.221476
AMA Nguyen H, Brals D, Tiemersma E, et al. Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017–2018. Emerging Infectious Diseases. 2023;29(5):967-976. doi:10.3201/eid2905.221476.
APA Nguyen, H., Brals, D., Tiemersma, E., Gasior, R., Nguyen, N., Nguyen, H....Cobelens, F. (2023). Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017–2018. Emerging Infectious Diseases, 29(5), 967-976. https://doi.org/10.3201/eid2905.221476.

Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana [PDF - 2.69 MB - 11 pages]
C. R. Baker et al.

Combining genomic and geospatial data can be useful for understanding Mycobacterium tuberculosis transmission in high-burden tuberculosis (TB) settings. We performed whole-genome sequencing on M. tuberculosis DNA extracted from sputum cultures from a population-based TB study conducted in Gaborone, Botswana, during 2012–2016. We determined spatial distribution of cases on the basis of shared genotypes among isolates. We considered clusters of isolates with ≤5 single-nucleotide polymorphisms identified by whole-genome sequencing to indicate recent transmission and clusters of ≥10 persons to be outbreaks. We obtained both molecular and geospatial data for 946/1,449 (65%) participants with culture-confirmed TB; 62 persons belonged to 5 outbreaks of 10–19 persons each. We detected geospatial clustering in just 2 of those 5 outbreaks, suggesting heterogeneous spatial patterns. Our findings indicate that targeted interventions applied in smaller geographic areas of high-burden TB identified using integrated genomic and geospatial data might help interrupt TB transmission during outbreaks.

EID Baker CR, Barilar I, de Araujo LS, Rimoin AW, Parker DM, Boyd R, et al. Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana. Emerg Infect Dis. 2023;29(5):977-987. https://doi.org/10.3201/eid2905.220796
AMA Baker CR, Barilar I, de Araujo LS, et al. Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana. Emerging Infectious Diseases. 2023;29(5):977-987. doi:10.3201/eid2905.220796.
APA Baker, C. R., Barilar, I., de Araujo, L. S., Rimoin, A. W., Parker, D. M., Boyd, R....Shin, S. S. (2023). Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana. Emerging Infectious Diseases, 29(5), 977-987. https://doi.org/10.3201/eid2905.220796.
Dispatches

Cutaneous Leishmaniasis Caused by Leishmania infantum, Israel, 2018–2021 [PDF - 2.00 MB - 4 pages]
M. Solomon et al.

Cutaneous leishmaniasis (CL) is endemic to Israel. Previously, CL caused by Leishmania infantum had been reported in Israel only once (in 2016). We report 8 L. infantum CL cases; 7 occurred during 2020–2021. None of the patients had systemic disease. L. infantum CL may be an emerging infection in Israel.

EID Solomon M, Astman N, Warshavsky K, Barzilai A, Meningher T, Avni D, et al. Cutaneous Leishmaniasis Caused by Leishmania infantum, Israel, 2018–2021. Emerg Infect Dis. 2023;29(5):988-991. https://doi.org/10.3201/eid2905.221812
AMA Solomon M, Astman N, Warshavsky K, et al. Cutaneous Leishmaniasis Caused by Leishmania infantum, Israel, 2018–2021. Emerging Infectious Diseases. 2023;29(5):988-991. doi:10.3201/eid2905.221812.
APA Solomon, M., Astman, N., Warshavsky, K., Barzilai, A., Meningher, T., Avni, D....Schwartz, E. (2023). Cutaneous Leishmaniasis Caused by Leishmania infantum, Israel, 2018–2021. Emerging Infectious Diseases, 29(5), 988-991. https://doi.org/10.3201/eid2905.221812.

Fatal Case of Heartland Virus Disease Acquired in the Mid-Atlantic Region, United States [PDF - 1.76 MB - 5 pages]
S. Liu et al.

Heartland virus (HRTV) disease is an emerging tickborne illness in the midwestern and southern United States. We describe a reported fatal case of HRTV infection in the Maryland and Virginia region, states not widely recognized to have human HRTV disease cases. The range of HRTV could be expanding in the United States.

EID Liu S, Kannan S, Meeks M, Sanchez S, Girone KW, Broyhill JC, et al. Fatal Case of Heartland Virus Disease Acquired in the Mid-Atlantic Region, United States. Emerg Infect Dis. 2023;29(5):992-996. https://doi.org/10.3201/eid2905.221488
AMA Liu S, Kannan S, Meeks M, et al. Fatal Case of Heartland Virus Disease Acquired in the Mid-Atlantic Region, United States. Emerging Infectious Diseases. 2023;29(5):992-996. doi:10.3201/eid2905.221488.
APA Liu, S., Kannan, S., Meeks, M., Sanchez, S., Girone, K. W., Broyhill, J. C....Hoffmann, C. J. (2023). Fatal Case of Heartland Virus Disease Acquired in the Mid-Atlantic Region, United States. Emerging Infectious Diseases, 29(5), 992-996. https://doi.org/10.3201/eid2905.221488.

Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea [PDF - 1.25 MB - 5 pages]
Y. Choi et al.

We report a case of occupational monkeypox virus infection from a needlestick injury in a healthcare worker in South Korea and review similar reports in the literature during 2022. Postexposure prophylactic treatment with a third-generation smallpox vaccine and antiviral agent tecovirimat inhibited local virus spread and alleviated lesion pain.

EID Choi Y, Jeon E, Kim T, Choi S, Moon SM, Song K, et al. Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea. Emerg Infect Dis. 2023;29(5):997-1001. https://doi.org/10.3201/eid2905.230028
AMA Choi Y, Jeon E, Kim T, et al. Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea. Emerging Infectious Diseases. 2023;29(5):997-1001. doi:10.3201/eid2905.230028.
APA Choi, Y., Jeon, E., Kim, T., Choi, S., Moon, S. M., Song, K....Kim, E. (2023). Case Report and Literature Review of Occupational Transmission of Monkeypox Virus to Healthcare Workers, South Korea. Emerging Infectious Diseases, 29(5), 997-1001. https://doi.org/10.3201/eid2905.230028.

Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021 [PDF - 798 KB - 5 pages]
N. Tam et al.

We analyzed 1,303 SARS-CoV-2 whole-genome sequences from Vietnam, and found the Alpha and Delta variants were responsible for a large nationwide outbreak of COVID-19 in 2021. The Delta variant was confined to the AY.57 lineage and caused >1.7 million infections and >32,000 deaths. Viral transmission was strongly affected by nonpharmaceutical interventions.

EID Tam N, Anh NT, Tung T, Thach P, Dung N, Trang V, et al. Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021. Emerg Infect Dis. 2023;29(5):1002-1006. https://doi.org/10.3201/eid2905.221787
AMA Tam N, Anh NT, Tung T, et al. Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021. Emerging Infectious Diseases. 2023;29(5):1002-1006. doi:10.3201/eid2905.221787.
APA Tam, N., Anh, N. T., Tung, T., Thach, P., Dung, N., Trang, V....Van Tan, L. (2023). Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021. Emerging Infectious Diseases, 29(5), 1002-1006. https://doi.org/10.3201/eid2905.221787.

Emerging Invasive Group A Streptococcus M1UK Lineage Detected by Allele-Specific PCR, England, 2020 [PDF - 881 KB - 4 pages]
X. Zhi et al.

Increasing reports of invasive Streptococcus pyogenes infections mandate surveillance for toxigenic lineage M1UK. An allele-specific PCR was developed to distinguish M1UK from other emm1 strains. The M1UK lineage represented 91% of invasive emm1 isolates in England in 2020. Allele-specific PCR will permit surveillance for M1UK without need for genome sequencing.

EID Zhi X, Li H, Li H, Loboda Z, Charles S, Vieira A, et al. Emerging Invasive Group A Streptococcus M1UK Lineage Detected by Allele-Specific PCR, England, 2020. Emerg Infect Dis. 2023;29(5):1007-1010. https://doi.org/10.3201/eid2905.221887
AMA Zhi X, Li H, Li H, et al. Emerging Invasive Group A Streptococcus M1UK Lineage Detected by Allele-Specific PCR, England, 2020. Emerging Infectious Diseases. 2023;29(5):1007-1010. doi:10.3201/eid2905.221887.
APA Zhi, X., Li, H., Li, H., Loboda, Z., Charles, S., Vieira, A....Sriskandan, S. (2023). Emerging Invasive Group A Streptococcus M1UK Lineage Detected by Allele-Specific PCR, England, 2020. Emerging Infectious Diseases, 29(5), 1007-1010. https://doi.org/10.3201/eid2905.221887.

Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021 [PDF - 340 KB - 4 pages]
L. Rubio et al.

Infection with Borrelia miyamotoi in California, USA, has been suggested by serologic studies. We diagnosed B. miyamotoi infection in an immunocompromised man in California. Diagnosis was aided by plasma microbial cell–free DNA sequencing. We conclude that the infection was acquired in California.

EID Rubio L, Kjemtrup AM, Marx GE, Cronan S, Kilonzo C, Saunders M, et al. Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021. Emerg Infect Dis. 2023;29(5):1011-1014. https://doi.org/10.3201/eid2905.221638
AMA Rubio L, Kjemtrup AM, Marx GE, et al. Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021. Emerging Infectious Diseases. 2023;29(5):1011-1014. doi:10.3201/eid2905.221638.
APA Rubio, L., Kjemtrup, A. M., Marx, G. E., Cronan, S., Kilonzo, C., Saunders, M....Park, S. Y. (2023). Borrelia miyamotoi Infection in Immunocompromised Man, California, USA, 2021. Emerging Infectious Diseases, 29(5), 1011-1014. https://doi.org/10.3201/eid2905.221638.

Novel Circovirus in Blood from Intravenous Drug Users, Yunnan, China [PDF - 2.72 MB - 5 pages]
Y. Li et al.

We identified a novel circovirus (human-associated circovirus 2 [HuCV2]) from the blood of 2 intravenous drug users in China who were infected with HIV-1, hepatitis C virus, or both. HuCV2 is most closely related to porcine circovirus 3. Our findings underscore the risk for HuCV2 and other emerging viruses among this population.

EID Li Y, Zhang P, Ye M, Tian R, Li N, Cao L, et al. Novel Circovirus in Blood from Intravenous Drug Users, Yunnan, China. Emerg Infect Dis. 2023;29(5):1015-1019. https://doi.org/10.3201/eid2905.221617
AMA Li Y, Zhang P, Ye M, et al. Novel Circovirus in Blood from Intravenous Drug Users, Yunnan, China. Emerging Infectious Diseases. 2023;29(5):1015-1019. doi:10.3201/eid2905.221617.
APA Li, Y., Zhang, P., Ye, M., Tian, R., Li, N., Cao, L....Zhang, C. (2023). Novel Circovirus in Blood from Intravenous Drug Users, Yunnan, China. Emerging Infectious Diseases, 29(5), 1015-1019. https://doi.org/10.3201/eid2905.221617.

Severe Streptococcus equi Subspecies zooepidemicus Outbreak from Unpasteurized Dairy Product Consumption, Italy [PDF - 2.01 MB - 5 pages]
S. Bosica et al.

During November 2021–May 2022, we identified 37 clinical cases of Streptococcus equi subspecies zooepidemicus infections in central Italy. Epidemiologic investigations and whole-genome sequencing showed unpasteurized fresh dairy products were the outbreak source. Early diagnosis by using sequencing technology prevented the spread of life-threatening S. equi subsp. zooepidemicus infections.

EID Bosica S, Chiaverini A, De Angelis M, Petrini A, Averaimo D, Martino M, et al. Severe Streptococcus equi Subspecies zooepidemicus Outbreak from Unpasteurized Dairy Product Consumption, Italy. Emerg Infect Dis. 2023;29(5):1020-1024. https://doi.org/10.3201/eid2905.221338
AMA Bosica S, Chiaverini A, De Angelis M, et al. Severe Streptococcus equi Subspecies zooepidemicus Outbreak from Unpasteurized Dairy Product Consumption, Italy. Emerging Infectious Diseases. 2023;29(5):1020-1024. doi:10.3201/eid2905.221338.
APA Bosica, S., Chiaverini, A., De Angelis, M., Petrini, A., Averaimo, D., Martino, M....Savini, G. (2023). Severe Streptococcus equi Subspecies zooepidemicus Outbreak from Unpasteurized Dairy Product Consumption, Italy. Emerging Infectious Diseases, 29(5), 1020-1024. https://doi.org/10.3201/eid2905.221338.

Characteristics and Treatment of Gordonia spp. Bacteremia, France [PDF - 334 KB - 4 pages]
A. Barthel et al.

Systemic Gordonia spp. infections are rare and occur mostly among immunocompromised patients. We analyzed 10 cases of Gordonia bacteremia diagnosed in 3 tertiary care centers in France to assess risk factors, treatment, and clinical outcomes. Most patients were cured within 10 days by using β-lactam antimicrobial therapy and removing central catheters.

EID Barthel A, Ursenbach A, Kaeuffer C, Koebel C, Gravet A, De Briel D, et al. Characteristics and Treatment of Gordonia spp. Bacteremia, France. Emerg Infect Dis. 2023;29(5):1025-1028. https://doi.org/10.3201/eid2905.221901
AMA Barthel A, Ursenbach A, Kaeuffer C, et al. Characteristics and Treatment of Gordonia spp. Bacteremia, France. Emerging Infectious Diseases. 2023;29(5):1025-1028. doi:10.3201/eid2905.221901.
APA Barthel, A., Ursenbach, A., Kaeuffer, C., Koebel, C., Gravet, A., De Briel, D....Gerber, V. (2023). Characteristics and Treatment of Gordonia spp. Bacteremia, France. Emerging Infectious Diseases, 29(5), 1025-1028. https://doi.org/10.3201/eid2905.221901.

No Substantial Histopathologic Changes in Mops condylurus Bats Naturally Infected with Bombali Virus, Kenya [PDF - 1.53 MB - 4 pages]
L. Kareinen et al.

We found similar mild perivascular inflammation in lungs of Bombali virus–positive and –negative Mops condylurus bats in Kenya, indicating the virus is well-tolerated. Our findings indicate M. condylurus bats may be a reservoir host for Bombali virus. Increased surveillance of these bats will be important to reduce potential virus spread.

EID Kareinen L, Airas N, Kotka ST, Masika MM, Aaltonen K, Anzala O, et al. No Substantial Histopathologic Changes in Mops condylurus Bats Naturally Infected with Bombali Virus, Kenya. Emerg Infect Dis. 2023;29(5):1029-1032. https://doi.org/10.3201/eid2905.221336
AMA Kareinen L, Airas N, Kotka ST, et al. No Substantial Histopathologic Changes in Mops condylurus Bats Naturally Infected with Bombali Virus, Kenya. Emerging Infectious Diseases. 2023;29(5):1029-1032. doi:10.3201/eid2905.221336.
APA Kareinen, L., Airas, N., Kotka, S. T., Masika, M. M., Aaltonen, K., Anzala, O....Forbes, K. M. (2023). No Substantial Histopathologic Changes in Mops condylurus Bats Naturally Infected with Bombali Virus, Kenya. Emerging Infectious Diseases, 29(5), 1029-1032. https://doi.org/10.3201/eid2905.221336.

Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern [PDF - 1.48 MB - 5 pages]
T. Bushmaker et al.

SARS-CoV-2 transmits principally by air; contact and fomite transmission may also occur. Variants of concern are more transmissible than ancestral SARS-CoV-2. We found indications of possible increased aerosol and surface stability for early variants of concern, but not for the Delta and Omicron variants. Stability changes are unlikely to explain increased transmissibility.

EID Bushmaker T, Yinda C, Morris DH, Holbrook MG, Gamble A, Adney D, et al. Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern. Emerg Infect Dis. 2023;29(5):1033-1037. https://doi.org/10.3201/eid2905.221752
AMA Bushmaker T, Yinda C, Morris DH, et al. Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern. Emerging Infectious Diseases. 2023;29(5):1033-1037. doi:10.3201/eid2905.221752.
APA Bushmaker, T., Yinda, C., Morris, D. H., Holbrook, M. G., Gamble, A., Adney, D....Munster, V. J. (2023). Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern. Emerging Infectious Diseases, 29(5), 1033-1037. https://doi.org/10.3201/eid2905.221752.

Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea [PDF - 350 KB - 4 pages]
S. Hatzl et al.

We investigated a prospective cohort of 23 patients who had Puumala virus infection in Austria to determine predictors of infection outcomes. We reviewed routinely available clinical and laboratory parameters collected when patients initially sought care. Low absolute lymphocyte count and dyspnea were parameters associated with a severe course of infection.

EID Hatzl S, Posch F, Linhofer M, Aberle S, Zollner-Schwetz I, Krammer F, et al. Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea. Emerg Infect Dis. 2023;29(5):1038-1041. https://doi.org/10.3201/eid2905.221625
AMA Hatzl S, Posch F, Linhofer M, et al. Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea. Emerging Infectious Diseases. 2023;29(5):1038-1041. doi:10.3201/eid2905.221625.
APA Hatzl, S., Posch, F., Linhofer, M., Aberle, S., Zollner-Schwetz, I., Krammer, F....Krause, R. (2023). Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea. Emerging Infectious Diseases, 29(5), 1038-1041. https://doi.org/10.3201/eid2905.221625.

Rustrela Virus as Putative Cause of Nonsuppurative Meningoencephalitis in Lions [PDF - 2.82 MB - 4 pages]
M. de le Roi et al.

Retrospective investigation of archived tissue samples from 3 lions displaying nonsuppurative meningoencephalitis and vasculitis led to the detection of rustrela virus (RusV). We confirmed RusV antigen and RNA in cortical neurons, axons, astrocytes and Purkinje cells by reverse transcription quantitative PCR, immunohistochemistry, and in situ hybridization.

EID de le Roi M, Puff C, Wohlsein P, Pfaff F, Beer M, Baumgärtner W, et al. Rustrela Virus as Putative Cause of Nonsuppurative Meningoencephalitis in Lions. Emerg Infect Dis. 2023;29(5):1042-1045. https://doi.org/10.3201/eid2905.230172
AMA de le Roi M, Puff C, Wohlsein P, et al. Rustrela Virus as Putative Cause of Nonsuppurative Meningoencephalitis in Lions. Emerging Infectious Diseases. 2023;29(5):1042-1045. doi:10.3201/eid2905.230172.
APA de le Roi, M., Puff, C., Wohlsein, P., Pfaff, F., Beer, M., Baumgärtner, W....Rubbenstroth, D. (2023). Rustrela Virus as Putative Cause of Nonsuppurative Meningoencephalitis in Lions. Emerging Infectious Diseases, 29(5), 1042-1045. https://doi.org/10.3201/eid2905.230172.

Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova [PDF - 1.65 MB - 5 pages]
E. Noroc et al.

Applying whole-genome-sequencing, we aimed to detect transmission events of multidrug-resistant/rifampin-resistant strains of Mycobacterium tuberculosis complex at a tuberculosis hospital in Chisinau, Moldova. We recorded ward, room, and bed information for each patient and monitored in-hospital transfers over 1 year. Detailed molecular and patient surveillance revealed only 2 nosocomial transmission events.

EID Noroc E, Chesov D, Merker M, Gröschel MI, Barilar I, Dreyer V, et al. Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova. Emerg Infect Dis. 2023;29(5):1046-1050. https://doi.org/10.3201/eid2905.230035
AMA Noroc E, Chesov D, Merker M, et al. Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova. Emerging Infectious Diseases. 2023;29(5):1046-1050. doi:10.3201/eid2905.230035.
APA Noroc, E., Chesov, D., Merker, M., Gröschel, M. I., Barilar, I., Dreyer, V....Lange, C. (2023). Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova. Emerging Infectious Diseases, 29(5), 1046-1050. https://doi.org/10.3201/eid2905.230035.

Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022 [PDF - 1.31 MB - 4 pages]
C. Rodriguez et al.

Hepatitis of undetermined origin can be caused by a wide variety of pathogens, sometimes emerging pathogens. We report the discovery, by means of routine shotgun metagenomics, of a new virus belonging to the family Circoviridae, genus Circovirus, in a patient in France who had acute hepatitis of unknown origin.

EID Rodriguez C, Boizeau L, Soulier A, N’Debi M, Demontant V, Trawinski E, et al. Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022. Emerg Infect Dis. 2023;29(5):1051-1054. https://doi.org/10.3201/eid2905.221485
AMA Rodriguez C, Boizeau L, Soulier A, et al. Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022. Emerging Infectious Diseases. 2023;29(5):1051-1054. doi:10.3201/eid2905.221485.
APA Rodriguez, C., Boizeau, L., Soulier, A., N’Debi, M., Demontant, V., Trawinski, E....Pawlotsky, J. (2023). Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022. Emerging Infectious Diseases, 29(5), 1051-1054. https://doi.org/10.3201/eid2905.221485.
Research Letters

Panton-Valentine Leukocidin–Positive CC398 MRSA in Urban Clinical Settings, the Netherlands [PDF - 437 KB - 3 pages]
J. Gooskens et al.

We report detection of Panton-Valentine leukocidin–positive clonal complex 398 human-origin methicillin-resistant Staphylococcus aureus L2 in the Netherlands. This hypervirulent lineage originated in the Asia-Pacific Region and could become community-acquired in Europe after recurrent travel-related introductions. Genomic surveillance enables early detection to guide control measures and help limit spread of pathogens in urban settings.

EID Gooskens J, Konstantinovski MM, Kraakman M, Kalpoe JS, van Burgel ND, Claas E, et al. Panton-Valentine Leukocidin–Positive CC398 MRSA in Urban Clinical Settings, the Netherlands. Emerg Infect Dis. 2023;29(5):1055-1057. https://doi.org/10.3201/eid2905.221717
AMA Gooskens J, Konstantinovski MM, Kraakman M, et al. Panton-Valentine Leukocidin–Positive CC398 MRSA in Urban Clinical Settings, the Netherlands. Emerging Infectious Diseases. 2023;29(5):1055-1057. doi:10.3201/eid2905.221717.
APA Gooskens, J., Konstantinovski, M. M., Kraakman, M., Kalpoe, J. S., van Burgel, N. D., Claas, E....Bosch, T. (2023). Panton-Valentine Leukocidin–Positive CC398 MRSA in Urban Clinical Settings, the Netherlands. Emerging Infectious Diseases, 29(5), 1055-1057. https://doi.org/10.3201/eid2905.221717.

Cystic Echinococcosis in Northern New Hampshire, USA [PDF - 500 KB - 2 pages]
A. AlSalman et al.

In April 2022 and December 2022, the New Hampshire Department of Health and Human Services confirmed 2 cases of locally acquired human pulmonary cystic echinococcosis caused by Echinococcus granulosus tapeworms. Both patients reported dressing locally hunted moose and exposure to dogs.

EID AlSalman A, Mathewson A, Martin IW, Mahatanan R, Talbot EA. Cystic Echinococcosis in Northern New Hampshire, USA. Emerg Infect Dis. 2023;29(5):1057-1058. https://doi.org/10.3201/eid2905.221828
AMA AlSalman A, Mathewson A, Martin IW, et al. Cystic Echinococcosis in Northern New Hampshire, USA. Emerging Infectious Diseases. 2023;29(5):1057-1058. doi:10.3201/eid2905.221828.
APA AlSalman, A., Mathewson, A., Martin, I. W., Mahatanan, R., & Talbot, E. A. (2023). Cystic Echinococcosis in Northern New Hampshire, USA. Emerging Infectious Diseases, 29(5), 1057-1058. https://doi.org/10.3201/eid2905.221828.

Mpox among Public Festival Attendees, Chicago, Illinois, USA, July–August 2022 [PDF - 550 KB - 3 pages]
E. Faherty et al.

We investigated an mpox outbreak after a 2022 LGBTQ event in Chicago, Illinois, USA. Among case-patients, 38% had received 1 dose of mpox vaccine, none 2 doses; most reported sexual activity during the probable exposure period. Among other preventive measures, persons at risk should complete mpox vaccination 14 days before an event.

EID Faherty E, Teran RA, Black SR, Chundi V, Smith S, Bernhardt B, et al. Mpox among Public Festival Attendees, Chicago, Illinois, USA, July–August 2022. Emerg Infect Dis. 2023;29(5):1059-1061. https://doi.org/10.3201/eid2905.221797
AMA Faherty E, Teran RA, Black SR, et al. Mpox among Public Festival Attendees, Chicago, Illinois, USA, July–August 2022. Emerging Infectious Diseases. 2023;29(5):1059-1061. doi:10.3201/eid2905.221797.
APA Faherty, E., Teran, R. A., Black, S. R., Chundi, V., Smith, S., Bernhardt, B....Kerins, J. L. (2023). Mpox among Public Festival Attendees, Chicago, Illinois, USA, July–August 2022. Emerging Infectious Diseases, 29(5), 1059-1061. https://doi.org/10.3201/eid2905.221797.

Burkholderia pseudomallei Laboratory Exposure, Arizona, USA [PDF - 262 KB - 3 pages]
L. J. Speiser et al.

We describe an incidental Burkholderia pseudomallei laboratory exposure in Arizona, USA. Because melioidosis cases are increasing in the United States and B. pseudomallei reservoirs have been discovered in the Gulf Coast Region, US laboratory staff could be at increased risk for B. pseudomallei exposure.

EID Speiser LJ, Graf EH, Seville M, Singbartl K, Dalton ML, Harrington D, et al. Burkholderia pseudomallei Laboratory Exposure, Arizona, USA. Emerg Infect Dis. 2023;29(5):1061-1063. https://doi.org/10.3201/eid2905.221865
AMA Speiser LJ, Graf EH, Seville M, et al. Burkholderia pseudomallei Laboratory Exposure, Arizona, USA. Emerging Infectious Diseases. 2023;29(5):1061-1063. doi:10.3201/eid2905.221865.
APA Speiser, L. J., Graf, E. H., Seville, M., Singbartl, K., Dalton, M. L., Harrington, D....Grys, T. E. (2023). Burkholderia pseudomallei Laboratory Exposure, Arizona, USA. Emerging Infectious Diseases, 29(5), 1061-1063. https://doi.org/10.3201/eid2905.221865.

Epizootic Hemorrhagic Disease Virus Serotype 8, Italy, 2022 [PDF - 454 KB - 3 pages]
A. Lorusso et al.

We describe the detection of epizootic hemorrhagic disease virus (EHDV) serotype 8 in cattle farms in Sardinia and Sicily in October–November 2022. The virus has a direct origin in North Africa; its genome is identical (>99.9% nucleotide sequence identity) to EHDV serotype 8 strains detected in Tunisia in 2021.

EID Lorusso A, Cappai S, Loi F, Pinna L, Ruiu A, Puggioni G, et al. Epizootic Hemorrhagic Disease Virus Serotype 8, Italy, 2022. Emerg Infect Dis. 2023;29(5):1063-1065. https://doi.org/10.3201/eid2905.221773
AMA Lorusso A, Cappai S, Loi F, et al. Epizootic Hemorrhagic Disease Virus Serotype 8, Italy, 2022. Emerging Infectious Diseases. 2023;29(5):1063-1065. doi:10.3201/eid2905.221773.
APA Lorusso, A., Cappai, S., Loi, F., Pinna, L., Ruiu, A., Puggioni, G....Savini, G. (2023). Epizootic Hemorrhagic Disease Virus Serotype 8, Italy, 2022. Emerging Infectious Diseases, 29(5), 1063-1065. https://doi.org/10.3201/eid2905.221773.

Human-to-Animal Transmission of SARS-CoV-2, South Korea, 2021 [PDF - 258 KB - 2 pages]
J. Bae et al.

To investigate SARS-CoV-2 transmission from humans to animals in Seoul, South Korea, we submitted samples from companion animals owned by persons with confirmed COVID-19. Real-time PCR indicated higher SARS-CoV-2 viral infection rates for dogs and cats than previously reported from the United States and Europe. Host-specific adaptations could introduce mutant SARS-CoV-2 to humans.

EID Bae J, Ro C, Kang Y, Ga E, Na W, Song D. Human-to-Animal Transmission of SARS-CoV-2, South Korea, 2021. Emerg Infect Dis. 2023;29(5):1066-1067. https://doi.org/10.3201/eid2905.221359
AMA Bae J, Ro C, Kang Y, et al. Human-to-Animal Transmission of SARS-CoV-2, South Korea, 2021. Emerging Infectious Diseases. 2023;29(5):1066-1067. doi:10.3201/eid2905.221359.
APA Bae, J., Ro, C., Kang, Y., Ga, E., Na, W., & Song, D. (2023). Human-to-Animal Transmission of SARS-CoV-2, South Korea, 2021. Emerging Infectious Diseases, 29(5), 1066-1067. https://doi.org/10.3201/eid2905.221359.

Norovirus GII.3[P25] in Patients and Produce, Chanthaburi Province, Thailand, 2022 [PDF - 512 KB - 4 pages]
W. Chuchaona et al.

An increase in acute gastroenteritis occurred in Chanthaburi Province, Thailand, during December 2021‒January 2022. Of the norovirus genotypes we identified in hospitalized patients and produce from local markets, genotype GII.3[P25] accounted for one third. We found no traceable link between patients and produce but found evidence of potential viral intake.

EID Chuchaona W, Khongwichit S, Luang-on W, Vongpunsawad S, Poovorawan Y. Norovirus GII.3[P25] in Patients and Produce, Chanthaburi Province, Thailand, 2022. Emerg Infect Dis. 2023;29(5):1067-1070. https://doi.org/10.3201/eid2905.221291
AMA Chuchaona W, Khongwichit S, Luang-on W, et al. Norovirus GII.3[P25] in Patients and Produce, Chanthaburi Province, Thailand, 2022. Emerging Infectious Diseases. 2023;29(5):1067-1070. doi:10.3201/eid2905.221291.
APA Chuchaona, W., Khongwichit, S., Luang-on, W., Vongpunsawad, S., & Poovorawan, Y. (2023). Norovirus GII.3[P25] in Patients and Produce, Chanthaburi Province, Thailand, 2022. Emerging Infectious Diseases, 29(5), 1067-1070. https://doi.org/10.3201/eid2905.221291.

COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia [PDF - 855 KB - 4 pages]
H. F. Gidding et al.

Using linked public health data from Australia to measure uptake of COVID-19 vaccination by infection status, we found coverage considerably lower among infected than uninfected persons for all ages. Increasing uptake of scheduled doses, including among previously infected persons after the recommended postinfection delay, is needed to reduce COVID-19 illness rates.

EID Gidding HF, Stepien S, Qian J, Macartney KK, Liu B. COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia. Emerg Infect Dis. 2023;29(5):1070-1073. https://doi.org/10.3201/eid2905.230047
AMA Gidding HF, Stepien S, Qian J, et al. COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia. Emerging Infectious Diseases. 2023;29(5):1070-1073. doi:10.3201/eid2905.230047.
APA Gidding, H. F., Stepien, S., Qian, J., Macartney, K. K., & Liu, B. (2023). COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia. Emerging Infectious Diseases, 29(5), 1070-1073. https://doi.org/10.3201/eid2905.230047.

Presence of Burkholderia pseudomallei in Soil, Nigeria, 2019 [PDF - 592 KB - 3 pages]
J. Savelkoel et al.

Melioidosis, caused by the soil-dwelling bacterium Burkholderia pseudomallei, is predicted to be endemic in Nigeria but is only occasionally reported. This report documents the systematic identification of the presence of B. pseudomallei and B. thailandensis in the soil across multiple states in Nigeria.

EID Savelkoel J, Oladele RO, Ojide CK, Peters RF, Notermans DW, Makinwa JO, et al. Presence of Burkholderia pseudomallei in Soil, Nigeria, 2019. Emerg Infect Dis. 2023;29(5):1073-1075. https://doi.org/10.3201/eid2905.221138
AMA Savelkoel J, Oladele RO, Ojide CK, et al. Presence of Burkholderia pseudomallei in Soil, Nigeria, 2019. Emerging Infectious Diseases. 2023;29(5):1073-1075. doi:10.3201/eid2905.221138.
APA Savelkoel, J., Oladele, R. O., Ojide, C. K., Peters, R. F., Notermans, D. W., Makinwa, J. O....Birnie, E. (2023). Presence of Burkholderia pseudomallei in Soil, Nigeria, 2019. Emerging Infectious Diseases, 29(5), 1073-1075. https://doi.org/10.3201/eid2905.221138.

Genome Analysis of Triploid Hybrid Leishmania Parasite from the Neotropics [PDF - 478 KB - 3 pages]
F. Van den Broeck et al.

We discovered a hybrid Leishmania parasite in Costa Rica that is genetically similar to hybrids from Panama. Genome analyses demonstrated the hybrid is triploid and identified L. braziliensis and L. guyanensis–related strains as parents. Our findings highlight the existence of poorly sampled Leishmania (Viannia) variants infectious to humans.

EID Van den Broeck F, Heeren S, Maes I, Sanders M, Cotton JA, Cupolillo E, et al. Genome Analysis of Triploid Hybrid Leishmania Parasite from the Neotropics. Emerg Infect Dis. 2023;29(5):1076-1078. https://doi.org/10.3201/eid2905.221456
AMA Van den Broeck F, Heeren S, Maes I, et al. Genome Analysis of Triploid Hybrid Leishmania Parasite from the Neotropics. Emerging Infectious Diseases. 2023;29(5):1076-1078. doi:10.3201/eid2905.221456.
APA Van den Broeck, F., Heeren, S., Maes, I., Sanders, M., Cotton, J. A., Cupolillo, E....Van der Auwera, G. (2023). Genome Analysis of Triploid Hybrid Leishmania Parasite from the Neotropics. Emerging Infectious Diseases, 29(5), 1076-1078. https://doi.org/10.3201/eid2905.221456.

New Genotype of Coxiella burnetii Causing Epizootic Q Fever Outbreak in Rodents, Northern Senegal [PDF - 698 KB - 4 pages]
J. Mangombi-Pambou et al.

In Senegal, Coxiella burnetii, which causes Q fever, has often been identified in ticks and humans near livestock, which are considered to be reservoirs and main sources of infection. We describe the emergence of C. burnetii in rodents, not previously known to carry this pathogen, and describe 2 new genotypes.

EID Mangombi-Pambou J, Granjon L, Labarrere C, Kane M, Niang Y, Fournier P, et al. New Genotype of Coxiella burnetii Causing Epizootic Q Fever Outbreak in Rodents, Northern Senegal. Emerg Infect Dis. 2023;29(5):1078-1081. https://doi.org/10.3201/eid2905.221034
AMA Mangombi-Pambou J, Granjon L, Labarrere C, et al. New Genotype of Coxiella burnetii Causing Epizootic Q Fever Outbreak in Rodents, Northern Senegal. Emerging Infectious Diseases. 2023;29(5):1078-1081. doi:10.3201/eid2905.221034.
APA Mangombi-Pambou, J., Granjon, L., Labarrere, C., Kane, M., Niang, Y., Fournier, P....Mediannikov, O. (2023). New Genotype of Coxiella burnetii Causing Epizootic Q Fever Outbreak in Rodents, Northern Senegal. Emerging Infectious Diseases, 29(5), 1078-1081. https://doi.org/10.3201/eid2905.221034.

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB [PDF - 545 KB - 4 pages]
J. Millard et al.

New classes of antitubercular drugs, diarylquinolines and nitroimidazoles, have been associated with improved outcomes in the treatment of drug-resistant tuberculosis, but that success is threatened by emerging drug resistance. We report a case of bedaquiline and delamanid resistance in a 55-year-old woman in South Africa with extensively drug-resistant tuberculosis and known HIV.

EID Millard J, Rimmer S, Nimmo C, O’Donnell M. Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB. Emerg Infect Dis. 2023;29(5):1081-1084. https://doi.org/10.3201/eid2905.221716
AMA Millard J, Rimmer S, Nimmo C, et al. Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB. Emerging Infectious Diseases. 2023;29(5):1081-1084. doi:10.3201/eid2905.221716.
APA Millard, J., Rimmer, S., Nimmo, C., & O’Donnell, M. (2023). Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB. Emerging Infectious Diseases, 29(5), 1081-1084. https://doi.org/10.3201/eid2905.221716.
Letters

Nomenclature for Human Infections Caused by Relapsing Fever Borrelia [PDF - 201 KB - 1 page]
P. S. Mead
EID Mead PS. Nomenclature for Human Infections Caused by Relapsing Fever Borrelia. Emerg Infect Dis. 2023;29(5):1084. https://doi.org/10.3201/eid2905.230195
AMA Mead PS. Nomenclature for Human Infections Caused by Relapsing Fever Borrelia. Emerging Infectious Diseases. 2023;29(5):1084. doi:10.3201/eid2905.230195.
APA Mead, P. S. (2023). Nomenclature for Human Infections Caused by Relapsing Fever Borrelia. Emerging Infectious Diseases, 29(5), 1084. https://doi.org/10.3201/eid2905.230195.
Online Reports

US National Institutes of Health Prioritization of SARS-CoV-2 Variants [PDF - 2.03 MB - 9 pages]
S. Turner et al.

Since late 2020, SARS-CoV-2 variants have regularly emerged with competitive and phenotypic differences from previously circulating strains, sometimes with the potential to escape from immunity produced by prior exposure and infection. The Early Detection group is one of the constituent groups of the US National Institutes of Health National Institute of Allergy and Infectious Diseases SARS-CoV-2 Assessment of Viral Evolution program. The group uses bioinformatic methods to monitor the emergence, spread, and potential phenotypic properties of emerging and circulating strains to identify the most relevant variants for experimental groups within the program to phenotypically characterize. Since April 2021, the group has prioritized variants monthly. Prioritization successes include rapidly identifying most major variants of SARS-CoV-2 and providing experimental groups within the National Institutes of Health program easy access to regularly updated information on the recent evolution and epidemiology of SARS-CoV-2 that can be used to guide phenotypic investigations.

EID Turner S, Alisoltani A, Bratt D, Cohen-Lavi L, Dearlove BL, Drosten C, et al. US National Institutes of Health Prioritization of SARS-CoV-2 Variants. Emerg Infect Dis. 2023;29(5):1-9. https://doi.org/10.3201/eid2905.221646
AMA Turner S, Alisoltani A, Bratt D, et al. US National Institutes of Health Prioritization of SARS-CoV-2 Variants. Emerging Infectious Diseases. 2023;29(5):1-9. doi:10.3201/eid2905.221646.
APA Turner, S., Alisoltani, A., Bratt, D., Cohen-Lavi, L., Dearlove, B. L., Drosten, C....Smith, D. J. (2023). US National Institutes of Health Prioritization of SARS-CoV-2 Variants. Emerging Infectious Diseases, 29(5), 1-9. https://doi.org/10.3201/eid2905.221646.
Corrections

Correction: Vol. 26, No. 12 [PDF - 201 KB - 1 page]
EID Correction: Vol. 26, No. 12. Emerg Infect Dis. 2023;29(5):1084. https://doi.org/10.3201/eid2905.c12905
AMA Correction: Vol. 26, No. 12. Emerging Infectious Diseases. 2023;29(5):1084. doi:10.3201/eid2905.c12905.
APA (2023). Correction: Vol. 26, No. 12. Emerging Infectious Diseases, 29(5), 1084. https://doi.org/10.3201/eid2905.c12905.
About the Cover

A Deadly Kiss [PDF - 701 KB - 2 pages]
B. Breedlove
EID Breedlove B. A Deadly Kiss. Emerg Infect Dis. 2023;29(5):1085-1086. https://doi.org/10.3201/eid2905.ac2905
AMA Breedlove B. A Deadly Kiss. Emerging Infectious Diseases. 2023;29(5):1085-1086. doi:10.3201/eid2905.ac2905.
APA Breedlove, B. (2023). A Deadly Kiss. Emerging Infectious Diseases, 29(5), 1085-1086. https://doi.org/10.3201/eid2905.ac2905.
Page created: April 19, 2023
Page updated: April 25, 2023
Page reviewed: April 25, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external